carbamates has been researched along with Multiple Myeloma in 7 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
Excerpt | Relevance | Reference |
---|---|---|
"Data are sparse on treatment of chronic hepatitis C virus (HCV) in cancer patients." | 1.51 | Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. ( Angelidakis, G; Blechacz, B; Economides, MP; Granwehr, BP; Hosry, J; Jiang, Y; Kaseb, A; Kyvernitakis, A; Mahale, P; Miller, E; Naing, A; Raad, II; Samaniego, F; Torres, HA, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, PJ | 1 |
O, Y | 1 |
Her, JH | 1 |
Yun, E | 1 |
Song, GY | 1 |
Oh, S | 1 |
Torres, HA | 1 |
Economides, MP | 1 |
Angelidakis, G | 1 |
Hosry, J | 1 |
Kyvernitakis, A | 1 |
Mahale, P | 1 |
Jiang, Y | 1 |
Miller, E | 1 |
Blechacz, B | 1 |
Naing, A | 1 |
Samaniego, F | 1 |
Kaseb, A | 1 |
Raad, II | 1 |
Granwehr, BP | 1 |
Lub, S | 1 |
Maes, A | 1 |
Maes, K | 1 |
De Veirman, K | 1 |
De Bruyne, E | 1 |
Menu, E | 1 |
Fostier, K | 1 |
Kassambara, A | 1 |
Moreaux, J | 1 |
Hose, D | 1 |
Leleu, X | 1 |
King, RW | 1 |
Vanderkerken, K | 1 |
Van Valckenborgh, E | 1 |
Ganai, SA | 1 |
Pahwa, P | 1 |
Karunanayake, CP | 1 |
Dosman, JA | 1 |
Spinelli, JJ | 1 |
McDuffie, HH | 1 |
McLaughlin, JR | 1 |
Nakagawa, Y | 1 |
Capetillo, S | 1 |
Jirgensons, B | 1 |
Luce, JK | 1 |
Bodey, GP | 1 |
1 review available for carbamates and Multiple Myeloma
Article | Year |
---|---|
Histone deacetylase inhibitor givinostat: the small-molecule with promising activity against therapeutically challenging haematological malignancies.
Topics: Antineoplastic Agents; Carbamates; Hematologic Neoplasms; Histone Deacetylase Inhibitors; Hodgkin Di | 2016 |
1 trial available for carbamates and Multiple Myeloma
Article | Year |
---|---|
Initial clinical trials with 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NCS-112682).
Topics: Alkynes; Antineoplastic Agents; Bone Marrow; Carbamates; Clinical Trials as Topic; Cyclohexanes; Eva | 1970 |
5 other studies available for carbamates and Multiple Myeloma
Article | Year |
---|---|
Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Carbamates; Cell Line, Tumor; Cell Proliferation; Co | 2017 |
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.
Topics: Aged; Antiviral Agents; Benzimidazoles; Breast Neoplasms; Carbamates; Carcinoma, Hepatocellular; Dru | 2019 |
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Wester | 2016 |
Multiple myeloma and exposure to pesticides: a Canadian case-control study.
Topics: Adult; Aged; Canada; Captan; Carbamates; Carbaryl; Case-Control Studies; Fungicides, Industrial; Hum | 2012 |
Effect of chemical modification of lysine residues on the conformation of human immunoglobulin G.
Topics: Anhydrides; Animals; Carbamates; Chemical Phenomena; Chemistry; Circular Dichroism; Goats; Humans; I | 1972 |